APA (7th ed.) Citation

S, C., S, G., & S, R. (2026). Design, Synthesis and Characterization of Anti-CTLA4 Peptide Conjugated Gemcitabine Prodrug Nanoparticles for Targeted Lung Cancer Chemoimmunotherapy. Pharmaceutical research. https://doi.org/10.1007/s11095-026-04147-8

Chicago Style (17th ed.) Citation

S, Chattopadhyay, Gayen S, and Roy S. "Design, Synthesis and Characterization of Anti-CTLA4 Peptide Conjugated Gemcitabine Prodrug Nanoparticles for Targeted Lung Cancer Chemoimmunotherapy." Pharmaceutical Research 2026. https://doi.org/10.1007/s11095-026-04147-8.

MLA (9th ed.) Citation

S, Chattopadhyay, et al. "Design, Synthesis and Characterization of Anti-CTLA4 Peptide Conjugated Gemcitabine Prodrug Nanoparticles for Targeted Lung Cancer Chemoimmunotherapy." Pharmaceutical Research, 2026, https://doi.org/10.1007/s11095-026-04147-8.